In a more recent study, we also found increased glucose consumption in cognitively unimpaired participants, which we were able to relate to increased CSF core AD biomarkers as well as increased CSF markers of neuroinflammation, including GFAP and YKL-40 [62]. This evidence concerns the gene CHI3L1 and Alzheimer disease.